Table 3. Hospitalization.*.
Key Secondary Outcome | LY-CoV555 | Placebo | Incidence |
---|---|---|---|
no. of patients/total no. | % | ||
Hospitalization | 9/143 | 6.3 | |
700 mg, 1/101 | 1.0 | ||
2800 mg, 2/107 | 1.9 | ||
7000 mg, 2/101 | 2.0 | ||
Pooled doses, 5/309 | 1.6 |
Data for patients who presented to the emergency department are included in this category.